Literature DB >> 16565978

Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin.

Shirui Mao1, Udo Bakowsky, Anchalee Jintapattanakit, Thomas Kissel.   

Abstract

Polyelectrolyte complexes (PEC) formed from chitosan derivatives and insulin was prepared and parameters influencing complex formation were characterized. Turbidimetric titration, in combination with dynamic light scattering (DLS) and laser doppler anemometry (LDA), were used to study the complexation process. The morphology of the PECs was determined using atomic force microscopy (AFM). PEC formation was predominantly pH-dependent. Complexation with insulin occurred only above critical pH value (pHc) of 6.0 for all the chitosan derivatives investigated. Soluble PECs in the size range of 200-500 nm with spherical or subspherical morphology and smooth surface structure were obtained at optimized polymer/insulin charge ratios. Optimal conditions were obtained when the pH of PECs was in the range of 6.5-8.0, depending on polymer structure. The stability of PECs was influenced by polymer chain length. Only when the MW of the polymers was > or =25-kDa PEC precipitation could be avoided. An increase in the ionic strength of the medium accelerated complex dissociation. Chitosan methylation and PEGylation significantly improved the stability of insulin in the PECs. Moreover, the PEC could protect insulin from degradation even at 50 degrees C for at least 6 h. All complexes could be lyophilized without influencing the particle size, complex concentration, and stability of insulin. On the basis of our results, we suggest that interactions involved in PEC formation were predominantly electrostatic in nature, involving the positively charged amino groups of chitosan and the negatively charged insulin above its isoelectric point. Intranasal absorption of the polyelectrolyte nanocomplexes will be studied in vivo. (c) 2006 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16565978     DOI: 10.1002/jps.20520

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  19 in total

Review 1.  Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.

Authors:  Anumita Chaudhury; Surajit Das
Journal:  AAPS PharmSciTech       Date:  2010-12-11       Impact factor: 3.246

2.  Enteric trimethyl chitosan nanoparticles containing hepatitis B surface antigen for oral delivery.

Authors:  Asma Farhadian; Naser Mohammadpour Dounighi; Mohammadreza Avadi
Journal:  Hum Vaccin Immunother       Date:  2015-07-09       Impact factor: 3.452

3.  Methotrexate-loaded chitosan- and glycol chitosan-based nanoparticles: a promising strategy for the administration of the anticancer drug to brain tumors.

Authors:  Adriana Trapani; Nunzio Denora; Giuliano Iacobellis; Johannes Sitterberg; Udo Bakowsky; Thomas Kissel
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

4.  Preparation, statistical optimization, and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan.

Authors:  Reza Mahjub; Farid Abedin Dorkoosh; Mohsen Amini; Mohammad Reza Khoshayand; Morteza Rafiee-Tehrani
Journal:  AAPS PharmSciTech       Date:  2011-10-27       Impact factor: 3.246

5.  Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin.

Authors:  Amani Elsayed; Mayyas Al-Remawi; Nidal Qinna; Asim Farouk; Khaldoun A Al-Sou'od; Adnan A Badwan
Journal:  AAPS PharmSciTech       Date:  2011-07-15       Impact factor: 3.246

Review 6.  An update on smart biocatalysts for industrial and biomedical applications.

Authors:  Akhilesh Kumar Shakya; Kutty Selva Nandakumar
Journal:  J R Soc Interface       Date:  2018-02       Impact factor: 4.118

7.  Composite carbohydrate interpenetrating polyelectrolyte nano-complexes (IPNC) as a controlled oral delivery system of citalopram HCl for pediatric use: in-vitro/in-vivo evaluation and histopathological examination.

Authors:  Rabab Kamel; Haidy Abbas; Mona El-Naa
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

8.  Chitosan-zinc-insulin complex incorporated thermosensitive polymer for controlled delivery of basal insulin in vivo.

Authors:  Mayura Oak; Jagdish Singh
Journal:  J Control Release       Date:  2012-08-07       Impact factor: 9.776

9.  Ex vivo evaluation of insulin nanoparticles using chitosan and arabic gum.

Authors:  M R Avadi; A M M Sadeghi; Naser Mohamadpour Dounighi; R Dinarvand; F Atyabi; M Rafiee-Tehrani
Journal:  ISRN Pharm       Date:  2011-07-10

10.  Low molecular weight chitosan-insulin polyelectrolyte complex: characterization and stability studies.

Authors:  Zakieh I Al-Kurdi; Babur Z Chowdhry; Stephen A Leharne; Mahmoud M H Al Omari; Adnan A Badwan
Journal:  Mar Drugs       Date:  2015-03-30       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.